Protalix BioTherapeutics, Inc. (PLX) Max Pain Analysis

Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.

Protalix BioTherapeutics, Inc. (PLX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $155.5M, listed on AMEX, employing roughly 213 people, carrying a beta of -0.01 to the broader market. Protalix BioTherapeutics, Inc. Led by Dror Bashan, public since 1998-05-15.

Snapshot as of May 15, 2026.

Spot Price
$2.02
Total OI
11.3K

Learn how max pain is reported and how to read the data →